TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Purchase of High Content Screening System

Wide field microscopes
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Scottish National Blood Transfusion Service: "Purchase of High Content Screening System". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityScottish National Blood Transfusion ServiceScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Scottish National Blood Transfusion Service
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Scottish National Blood Transfusion Service. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
2.3Bids / Report
30% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 16 active published awards; 10 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published27 Jan 2021, 09:56 GMT
Last source update27 Jan 2021, 09:56 GMT
Recurring procurementNot published
ClassificationWide field microscopes
Delivery area
OCIDocds-h6vhtk-028d97
What is being bought
Delivery of an Operetta CLS high-content screening system
What changed
From the official release history
  1. Status changed to complete
    27 Jan 2021, 09:56 GMT
  2. Official notice release published
    27 Jan 2021, 09:56 GMT
  3. Buyer information updated
    27 Jan 2021, 09:56 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    Status not published
    Published valueNot published
    Supply, installation and training of High Content Screening System Operetta CLS equipment for the detailed analysis of a variety of cell types (including rare cells such as stem cells and antigen-specific T cells) and for more specialist applications including: imaging of primary cells, live cells and cells cultured in 3D systems, tumorigenesis analysis including colony detection, phagocytosis assays, size and shape analysis, quantification of cells/colonies and fluorescence; by TCAT (Tissues, Cells and Advanced Therapeutics), Scottish National Blood Transfusion Service (SNBTS). The following specific aspects of operetta CLS are strictly necessary for our research and are not provided by any other provider: — With 8 high-performance LEDs, the Operetta CLS offers an unsurpassed variety of excitation wavelengths for the entire range between ultraviolet and near-infrared. This flexibility is of immense importance for QC development of a wide variety of assays — The Operetta CLS has a user-accessible 8-position emission filter wheel, which can be equipped with barcode filters for error-free operation, and for optimal coincidence between excitation and emission source. .— The Operetta CLS can be equipped with 3 automated water immersion lenses with high numerical aperture of various magnifications (20x, 40x, 63x). This shortens the measurement time and improves the resolution in the z-direction; overall, this increases throughput in the analysis of three-dimensional structures. This is necessary for the exact analysis of the many different samples that are measured in our central department (tissue sections, tumor organoids, cell culture experiments, etc.). This technology is patented: EP1386189 B1, US7304793 B2 and EP1646902 B1, US7961384 B2. — The system automatically corrects displacements resulting from the 5x to the 40x or 63x lens by means of a fluorescent reference sample (QuasiperiodicGrid) firmly installed in the table. This ensures that the desired cells, cell complexes, or cell structures can be found again and again at the right level. Perkin Elmer also has a patent (US9582864). The ability to pre-scan and return to the same spot reduces the amount of time that cells are expose3d to incident illumination and therefore limits damage to the cells, this allows repeat analysis and temporal tracking. — That the equipment software offers advanced morphological characteristics that allow the quantification of various aspects of the shape and structure of objects, for example: elongation, symmetry, smoothness of the edge and spatial distribution of the intensity of the texture characteristics, — The system offers a method for machine learning (PhenoLOGIC) during analysis. This allows the software to identify different cell populations or regions and then automatically set the best parameters for optimal image segmentation and cell classification (patents to PhenoLOGIC:WO2013038224).
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    27 Jan 2021, 09:56 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 22 Jan 2021, 00:00 GMT · Not published
Commercial outcome and competition
Awards
Perkin Elmer
Not published · Not published · active
Contracts
Contract
Not published · signed 22 Jan 2021, 00:00 GMT · active
Bid statistics
highestValidBidValue: 300000
lowestValidBidValue: 200000
highestValidBidValue: 300000 (lot 1)
lowestValidBidValue: 200000 (lot 1)
Buyer and organisations in this procedure

Scottish National Blood Transfusion Service

Contracting authority GB-FTS-667
View buyer profile
  • Scottish National Blood Transfusion Service
    buyer

    The Jack Copland Centre, 52 Research Avenue, Heriot-Watt Research Park, Edinburgh, UKM, EH14 4BE
    +44 1313145603
  • Edinburgh Sheriff Court
    reviewBody

    Sheriff Court House, Edinburgh, EH1 1LB
  • Perkin Elmer
    supplier

    Chalfont Road, Seer Green, Beaconsfield, UK, HP9 2FX
    +44 800896046
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleThe following specific and unique selling points of operetta CLS are strictly necessary for our research and are not provided by any other provider: — With 8 high-performance LEDs, the Operetta CLS offers an unsurpassed variety of excitation wavelengths for the entire range between ultraviolet and near-infrared. This flexibility is of immense importance for QC development of a wide variety of assays — The Operetta CLS has a user-accessible 8-position emission filter wheel, which can be equipped with barcode filters for error-free operation, and for optimal coincidence between excitation and emission source. .— The Operetta CLS can be equipped with 3 automated water immersion lenses with high numerical aperture of various magnifications (20x, 40x, 63x). This shortens the measurement time and improves the resolution in the z-direction; overall, this increases throughput in the analysis of three-dimensional structures. This is necessary for the exact analysis of the many different samples that are measured in our central department (tissue sections, tumor organoids, cell culture experiments, etc.). This technology is patented: EP1386189 B1, US7304793 B2 and EP1646902 B1, US7961384 B2. — The system automatically corrects displacements resulting from the 5x to the 40x or 63x lens by means of a fluorescent reference sample (QuasiperiodicGrid) firmly installed in the table. This ensures that the desired cells, cell complexes, or cell structures can be found again and again at the right level. Perkin Elmer also has a patent (US9582864). The ability to pre-scan and return to the same spot reduces the amount of time that cells are expose3d to incident illumination and therefore limits damage to the cells, this allows repeat analysis and temporal tracking. — That the equipment software offers advanced morphological characteristics that allow the quantification of various aspects of the shape and structure of objects, for example: elongation, symmetry, smoothness of the edge and spatial distribution of the intensity of the texture characteristics, — The system offers a method for machine learning (PhenoLOGIC) during analysis. This allows the software to identify different cell populations or regions and then automatically set the best parameters for optimal image segmentation and cell classification (patents to PhenoLOGIC:WO2013038224).